Bone Marrow Transplantation
On Oct. 20, E. Donnall Thomas, the “father of bone marrow transplantation,” died at age 92.
News & Commentaries
Stem Cells and Neurodegeneration
On July 26, the California Institute of Regenerative Medicine announced $151 million worth of grants for research that would take stem cell therapies from the laboratory to the clinic.
MSCs and bone repair
Two years ago, Pamela Robey broke two bones in her leg, a consequence of snow outside and an errant boot. “I slipped and my boot heel got caught in a crack,” she says. “I was moving very fast but my leg was not.”
Spermatogonial stem cells
If there is a scientific analog of having one’s cake and eating it too, it would have to be iPS cells.
Stem cells in the eye
The stem cell community recorded something of a milestone this past month.
Genome editing
In the Oct. 20 issue of Nature, researchers at the Wellcome Trust Sanger Institute and Sangamo BioSciences, reported some dramatic results in the field of stem cell therapeutics. [1]
The Evolving Regenerative Medicine Business Model; Concept and Funding
The fast-paced, vibrant world of stem cell science has more than its fair share of brilliant minds. Many probably have at one time or another considered striking out on their own to market some new invention from their lab.
Targeting tumors through cancer stem cells
Human development is the work of stem cells.
In vivo Stem Cell Imaging-Regulatory Challenges and Advances
On April 19, Geron Corp. presented safety data on the first patient in its groundbreaking clinical trial of GRNOPC1.
First human trials of embryonic stem cell-based therapies head to the clinic
On January 3, stem cell therapeutics company Advanced Cell Technology (ACT) announced it had received approval from the US Food and Drug Administration to kick off a Phase I/II clinical trial using the company's retinal epithelial cells (RPE).